Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.03 | 16.67 |
| PEG Ratio (TTM) | 13.00 | 2.15 |
| P/S Ratio (TTM) | 0.89 | 1.67 |
| P/B Ratio (TTM) | 1.66 | 3.04 |
| P/FCF Ratio (TTM) | 13.39 | 10.48 |
| Price to 5YR AVG Earnings Ratio | -15.66 | 2.19 |
| Price to 5YR AVG FCF Ratio | 28.39 | 33.84 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.45% | 7.52% |
| ROE (TTM) | 7.67% | 17.68% |
| Net Profit Margin (TTM) | 4.05% | 9.40% |
| ROIC 5YR AVG | -9.24% | 6.20% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.15% | -3,082.94% | -1,807.17% |
| Revenue | -1.15% | -14.10% | 10.68% |
| Net Income | 70.80% | -3,271.38% | -1,912.62% |
| Cash Flow | 7.53% | -58.57% | 177.50% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 1.84 |
| Quick Ratio (TTM) | 1.62 | 1.33 |
| D/E Ratio (TTM) | 0.12 | 1.08 |
| Interest Coverage (TTM) | 12.37 | 16.90 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 2.92 | 2.92 |
| LTL to 5YR AVG FCF | 0.82 | 8.39 |
| Shares Outstanding Growth 5YR AVG | 9.89% | 6.58% |